Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kyowa Kirin Co., Ltd.
Age
55–84
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with mild to moderate Alzheimer's Disease
Body weight ≥ 40 kg and \< 100 kg
Clinical Dementia Rating (CDR) score of 1 or 2
Mini Mental State Examination (MMSE) score of ≥ 17 amd ≤ 26
You may not be if
Previous active treatment with an Alzheimer's Disease immunotherapy in an investigational study
Use of another investigational drug within 16 weeks prior to the enrollment
Subjects who meet National Institute of Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS/AIREN) criteria for vascular dementia
Subjects with a history of presence of clinically significant seizures, brain trauma, transient ischemic attack, and/or cerebrovascular disease
Subjects with a presence of a neurological condition that could be contributing to cognitive impairment above and beyond that caused by the subject's Alzheimer's Disease
Subjects who have evidence of infection, tumor, or other clinically significant lesions that could indicate a dementia diagnosis other than Alzheimer's Disease
